Virios Therapeutics Stock (NASDAQ: VIRI) stock price, news, charts, stock research, profile.
|Vol / Avg.94.896K / 423.060K||Mkt Cap11.555M|
|Day Range0.565 - 0.600||52 Wk Range0.220 - 2.420|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2022-09-20||HC Wainwright & Co.||Sean Lee||Downgrades||BuyNeutral||-||-||-|
|2021-12-15||HC Wainwright & Co.||Sean Lee||Initiates Coverage On||Buy||Announces||-||12.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Virios Therapeutics (NASDAQ: VIRI) through any online brokerage.
The latest price target for Virios Therapeutics (NASDAQ: VIRI) was reported by HC Wainwright & Co. on Tuesday, September 20, 2022. The analyst firm set a price target for 0.00 expecting VIRI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Virios Therapeutics (NASDAQ: VIRI) is $0.6 last updated Today at December 1, 2023 at 12:59 AM UTC.
There is no dividend information for Virios Therapeutics.
Virios Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Virios Therapeutics.
Virios Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.